Immunohistochemical expression and prognostic relevance of Bmi-1, a stem cell factor, in epithelial ovarian cancer

Annals of Diagnostic Pathology

Volumn 18, Issue 2, 2014, Pages 58-62

  Abd El Hafez, Amal ^a   El Hadaad, Hend Ahmed ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Bmi 1; Epithelial ovarian cancer; Immunohistochemistry; Prognosis; Survival

Indexed keywords

BMI1 PROTEIN;

ADULT; ARTICLE; CANCER GRADING; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; COLLOID CARCINOMA; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; OVARY CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; YOUNG ADULT;

BMI-1; EPITHELIAL OVARIAN CANCER; IMMUNOHISTOCHEMISTRY; PROGNOSIS; SURVIVAL;

ADULT; AGED; CYSTADENOCARCINOMA, SEROUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MIDDLE AGED; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; PARAFFIN EMBEDDING; POLYCOMB REPRESSIVE COMPLEX 1; PROGNOSIS; STEM CELL FACTOR; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84896402098     PISSN: 10929134     EISSN: 15328198     Source Type: Journal    
DOI: 10.1016/j.anndiagpath.2013.11.004     Document Type: Article

References (41)

1. R. Agarwal, and S.B. Kaye Prognostic factors in ovarian cancer: how close are we to a complete picture? Ann Oncol 16 2005 4 6.
2. D.A. Bell Origins and molecular pathology of ovarian cancer Mod Pathol 18 2005 S19 S32.
3. K.M. Freund, N.C. Dolan, and H.D. Nelson Update in women's health Ann Int Med 138 2003 119 127.
4. R. Bhattacharya, M. Nicoloso, and R. Arvizo et al. MiR-15a and MiR-16 control Bmi-1 expression in ovarian cancer Cancer Res 69 2009 9090 9095.
5. T. Lapidot, C. Sirard, and J. Vormoor et al. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice Nature 367 1994 645 648.
6. G. Bertolini, L. Roz, and P. Perego et al. Highly tumorigenic lung cancer CD133p cells display stem-like features and are spared by cisplatin treatment Proc Natl Acad Sci U S A 106 2009 16281 16286.
7. L. Cao, J. Bombard, and K. Cintron et al. Bmi-1 as a novel target for drug discovery in cancer J Cell Biochem 112 2011 2729 2741.
8. F. Crea, M.A. Duhagon-Serrat, and E.M. Hurt et al. Bmi-1 silencing enhances docetaxel activity and impairs antioxidant response in prostate cancer Int J Cancer 128 2011 1946 1954.
9. G.F. Huber, A. Albinger-Hegyi, and A. Soltermann et al. Expression patterns of Bmi-1 and p16 significantly correlate with overall, disease-specific, and recurrence-free survival in oropharyngeal squamous cell carcinoma Cancer 117 2011 4659 4670.
10. F.M. Raaphorst Deregulated expression of Polycomb-group oncogenes in human malignant lymphomas and epithelial tumors Hum Mol Genet 1 2005 R93 R100.
11. G.P. Dimri, J.L. Martinez, and J.J. Jacobs et al. The Bmi-1 oncogene induces telomerase activity and immortalizes human mammary epithelial cells Cancer Res 62 2002 4736 4745.
12. I.K. Park, S.J. Morrison, and M.F. Clarke Bmi-1, stem cells, and senescence regulation J Clin Invest 113 2004 175 179.
13. J.J. Jacobs, K. Kieboom, and S. Marino et al. The oncogene and Polycomb group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus Nature 397 1999 164 168.
14. A.V. Molofsky, S. He, and M. Bydon et al. Bmi-1 promotes neural stem cell self-renewal and neural development but not mouse growth and survival by repressing the p16Ink4a and p19Arf senescence pathways Genes Dev 19 2005 1432 1437.
15. J. Lessard, and G. Sauvageau Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells Nature 423 2003 255 260.
16. L.B. Song, M.S. Zeng, and W.T. Liao et al. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells Cancer Res 66 2006 6225 6232.
17. F. Zhang, L. Sui, and T. Xin Correlations of Bmi-1 expression and telomerase activity in ovarian cancer tissues Exp Oncol 30 2008 70 74.
18. H.R. Siddique, and M. Saleem Role of Bmi-1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences Stem Cells 30 2012 372 378.
19. S. Beà, F. Tort, and M. Pinyol et al. Bmi-1 gene amplification and overexpression in hematological malignancies occur mainly in mantle cell lymphomas Cancer Res 61 2011 2409 2412.
20. F.G. van Kemenade, F.M. Raaphorst, and T. Blokzijl et al. Coexpression of Bmi-1 and EZH2 polycomb-group proteins is associated with cycling cells and degree of malignancy in B-cell non-Hodgkin lymphoma Blood 97 2001 3896 3904.
21. S. Vonlanthen, J. Heighway, and H.J. Altermatt et al. The Bmi-1 oncoprotein is differentially expressed in non-small cell lung cancer and correlates with INK4A-ARF locus expression Br J Cancer 84 2001 1372 1376.
22. J.H. Kim, S.Y. Yoon, and S.H. Jeong et al. Overexpression of Bmi-1 oncoprotein correlates with axillary lymph node metastases in invasive ductal breast cancer Breast 13 2004 383 388.
23. R.H. Breuer, P.J. Snijders, and G.T. Sutedja et al. Expression of the p16(INK4a) gene product, methylation of the p16(INK4a) promoter region and expression of the polycomb-group gene Bmi-1 in squamous cell lung carcinoma and premalignant endobronchial lesions Lung Cancer 48 2005 299 306.
24. K. Mihara, M. Chowdhury, and N. Nakaju et al. Bmi-1 is useful as a novel molecular marker for predicting progression of myelodysplastic syndrome and prognosis of the patients Blood 107 2006 305 308.
25. H. Cui, B. Hu, and T. Li et al. Bmi-1 is essential for the tumorigenicity of neuroblastoma cells Am J Pathol 170 2007 1370 1378.
26. Z.K. Qin, J.A. Yang, and Y.L. Ye et al. Expression of Bmi-1 is a prognostic marker in bladder cancer BMC Cancer 19 2009 61 10.1186/1471-2407-9- 61.
27. W.L. Liu, X.Z. Guo, and L.J. Zhang et al. Prognostic relevance of Bmi-1 expression and autoantibodies in esophageal squamous cell carcinoma BMC Cancer 10 2010 467 10.1186/1471-2407-10-467.
28. Y.W. Lu, J. Li, and W.J. Guo Expression and clinicopathological significance of Mel-18 and Bmi-1 mRNA in gastric carcinoma J Exp Clin Cancer Res 29 2010 143 10.1186/1756-9966-29-143.
29. M.L. Riis, T. Lüders, and A.J. Nesbakken et al. Expression of Bmi-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer BMC Cancer 10 2010 686 10.1186/1471-2407-10-686.
30. B.H. Guo, Y. Feng, and R. Zhang et al. Bmi-1 promotes invasion and metastasis, and its elevated expression is correlated with an advanced stage of breast cancer Mol Cancer 10 2011 10 10.1186/1476-4598-10-10.
31. R. Yoshikawa, T. Tsujimura, and L. Tao et al. The oncoprotein and stem cell renewal factor Bmi-1 associates with poor clinical outcome in oesophageal cancer patients undergoing preoperative chemoradiotherapy BMC Cancer 12 2012 461 10.1186/1471-2407-12-461.
32. E. Proctor, M. Waghray, and C.J. Lee et al. Bmi-1 enhances tumorigenicity and cancer stem cell function in pancreatic adenocarcinoma PLoS One 8 2013 e55820 10.1371/journal.pone.0055820.
33. H.R. Siddique, A. Parray, and W. Zhong et al. Bmi-1, stem cell factor acting as novel serum-biomarker for Caucasian and African-American prostate cancer PLoS One 8 2013 e52993 10.1371/journal.pone.0052993.
34. E. Wang, S. Bhattacharyya, and A. Szabolcs et al. Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer PLoS One 6 2011 e17918 10.1371/journal.pone.0017918.
35. T. Xin, F.B. Zhang, and G.J. Sui et al. Bmi-1 siRNA inhibited ovarian cancer cell line growth and decreased telomerase activity Br J Biomed Sci 69 2012 62 66.
36. G.F. Yang, W.P. He, and M.Y. Cai et al. Intensive expression of Bmi-1 is a new independent predictor of poor outcome in patients with ovarian carcinoma BMC Cancer 10 2010 133 10.1186/1471-2407-10-133.
37. S.A. Cannistra Cancer of the ovary N Engl J Med 351 2004 2519 2529.
38. O.P. Berezovska, A.B. Glinskii, and Z. Yang et al. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer Cell Cycle 5 2006 1886 1901.
39. G.V. Glinsky, O. Berezovska, and A.B. Glinskii Microarray analysis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer J Clin Invest 115 2005 1503 1521.
40. K. Itahana, Y. Zou, and Y. Itahana et al. Control of the replicative life span of human fibroblasts by p16 and the polycomb protein Bmi-1 Mol Cell Biol 23 2003 389 401.
41. A. Honig, C. Weidler, and S. Häusler et al. Overexpression of polycomb protein BMI-1 in human specimens of breast, ovarian, endometrial and cervical cancer Anticancer Res 30 2010 1559 1564